Jeffery H. Moran

High Impact

Assistant Professor

UAMS

Last publication 2026 Last refreshed 2026-05-16

faculty

Pharmacology & Toxicology, College of Medicine

29 h-index 83 pubs 3,749 cited

Research Areas

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Jeffery H. Moran's research focuses on the pharmacokinetic and pharmacodynamic properties of various substances, with a particular emphasis on drug metabolism, antinociception, dependence, and withdrawal. His work investigates the effects of both prescribed and illicit compounds, utilizing animal models and advanced analytical techniques such as tandem mass spectrometry.

Moran has published research on the safety of acetaminophen in patients with cirrhosis and the pharmacokinetics of bleomycin in vascular malformations. He has also explored novel applications in drug testing, including hands-free analytical urine testing for drug-facilitated crime investigations and modifications to laboratory testing during the COVID-19 pandemic. His scholarship metrics include an h-index of 29, 79 total publications, and 3,727 total citations, designating him as a highly cited researcher. He maintains collaborations with researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi and Marina Avram.

Metrics

h-index: 29
Publications: 83
Citations: 3,749

Selected Publications

Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses (2026)

DOI OpenAlex
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)

2 citations DOI OpenAlex
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)

2 citations DOI OpenAlex
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)

4 citations DOI OpenAlex
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2023)

4 citations DOI OpenAlex
Development of a clinical and translational research curriculum for undergraduate students (2023)

7 citations DOI OpenAlex
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2022)

DOI OpenAlex
Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations (2022)

12 citations DOI OpenAlex
The Spice of Death (2021)

6 citations DOI OpenAlex
Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis (2021)

22 citations DOI OpenAlex
55715 Quantification of Neonatal THC Exposure Following Prenatal Marijuana Use (2021)

DOI OpenAlex
Modifying laboratory testing via home brew during the COVID-19 pandemic (2021)

3 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

No FP attached UAMS ACHRI Flow Through Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator
Reduced Temperature Thermal Ablation for HCC and other Liver Tumors NIH Co-Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator
Metabolomics of menthol cigarette smoking and risk for aggressive prostate cancer among African-American men US Department of Defense Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator